A list of drugs used for the treatment of nausea. The chart includes the formulations, strengths, and usual doses for each antiemetic drug product.
The novelty of immunotherapies means that physicians and patients lack extensive experience dealing with them.
This study's information can inform policy issues, particularly the collection of patient-reported outcome data and its use in clinical practice.
Study authors suggest that oncologists and oncology providers can help design effective, personalized workplace accommodations for patients with cancer.
Patients who reported better clinician communication or an improved satisfaction with their treatment were more likely to be adherent.
Interprofessional practice provides benefits to patients, team members, and the health care system, by working collaboratively to support and assist each other.
According to the AACI, proposed budget cuts by the White House would likely mean a cut of close to $1 billion for the National Cancer Institute.
The Hospital Readmission Reduction Program may unfairly penalize hospitals if 30-day readmission rates are the only metric for care quality.
Electroencephalogram neurofeedback appears to be effective at alleviating symptoms of chemotherapy-induced peripheral neuropathy.
The FDA has approved telotristat ethyl (Xermelo) for the treatment of adults with carcinoid syndrome diarrhea in combination with somatostatin analog.
Adding in-house specialty pharmacies to cancer centers improves quality of care and reduces medication errors for patients taking oral anticancer therapies.
Among patients with breast or prostate cancers, mental health conditions are associated with increased outpatient visits, hospital admissions.
ASCO released a statement condemning the implicit limitations to medical advances of the immigration restrictions imposed by President Trump.
Participation in a coaching session with a question prompt list (QPL) increased the number of questions asked by patients during an oncology visit.
The FDA has approved morphine sulfate extended-release tablets (Arymo ER) for the management of pain.
Dr Barbara Burtness of Yale University's School of Medicine discusses the relationship between happiness and clinical practice in oncology.
Differences between the sexes are known in a variety of cancers, but the reasons remain unclear.
CTA spoke with Judith A. Paice, PhD, RN, to better understand how clinicians are reacting to these legalizations and how she responds to patients asking about cannabis use.
In screening for mood disorders among patients with cancer, the PHQ-2 diagnostic tool demonstrates effective psychometric properties.
Financial hardship is common among cancer survivors in the US, and can be a psychologically and economically debilitating burden.
Many patients with cancer who receive intravenous chemotherapy who are at low emetic risk may receive unnecessary prophylactic antiemetic drug treatment.
The American Society of Clinical Oncology Clinical Practice Guideline on the integration of palliative care into standard oncology care has been updated.
This inexpensive, web-based treatment may help patients overcome cognitive issues from chemotherapy.
Educating the public about risk factors and prevention strategies remains a major challenge to cancer prevention.
Patients with multiple myeloma who received care at higher-volume treatment facilities had a lower risk of death.
Chronic health conditions related to previous cancer treatments may cause emotional distress among survivors.
Denosumab (Xgeva) is non-inferior to zoledronic acid in delaying the time to first on-study skeletal-related event among patients with multiple myeloma.
Among patients with pancreatic ductal adenocarcinoma (PDAC), the use of gene signature-based subtyping may guide personalized therapy.
Adequate follow-up may be needed to prevent suicide among young cancer survivors.
There was a decrease in cancer mortality from 1999 to 2014 for children and adolescents aged 1 to 19 years.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy